Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities
Publication year
2020Number of pages
9 p.
Source
Developmental Medicine & Child Neurology, 62, 3, (2020), pp. 354-362ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Rehabilitation
SW OZ BSI OLO
Paediatrics
Journal title
Developmental Medicine & Child Neurology
Volume
vol. 62
Issue
iss. 3
Languages used
English (eng)
Page start
p. 354
Page end
p. 362
Subject
All institutes and research themes of the Radboud University Medical Center; Learning and Plasticity; Radboudumc 0: Other Research DCMN: Donders Center for Medical Neuroscience; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical NeuroscienceAbstract
Aims: To examine changes in objective and subjective drooling severity measures after submandibular botulinum neurotoxin A injection in children with neurodevelopmental disabilities, explore their relationship, and evaluate if clinically relevant responses relate to changes in the impact of drooling. Method: This longitudinal, observational cohort study involved 160 children (92 males, 68 females; 3-17y, mean 9y 1mo, SD 3y 6mo) treated between 2000 and 2012 at the Radboud University Medical Center, Nijmegen, the Netherlands. Repeated measures analysis of variance was used to compare the 5‐minute Drooling Quotient (DQ5) and Visual Analogue Scale (VAS) for drooling severity pretreatment and posttreatment, and Pearson’s rho to assess their association. A parent questionnaire was used to assess drooling impact in responders (defined as ≥50% reduction in DQ5 and/or ≥2 SD reduction in VAS for drooling severity 8wks postintervention) and non‐responders.
Results: One hundred and twelve children (70%) were responders. Their mean VAS for drooling severity and DQ5 scores were significantly lower 32 weeks postintervention compared to baseline. At baseline, the VAS for drooling severity‐DQ5 relationship was 'weak' (rs=0.15, p=0.060), whereas it was 'fair' at 8 weeks (rs=0.43, p=0.000) and 32 weeks (rs=0.30, p=0.000). For responders, a significant change was found regarding the impact of drooling on daily care and social interactions at 8 weeks after intervention; most of these effects were maintained at 32 weeks. Interpretation: A clinically relevant response based on a combination of objective and subjective measures of drooling severity was accompanied by positive changes regarding the impact of drooling on daily care and social interactions.
This item appears in the following Collection(s)
- Academic publications [227425]
- Electronic publications [107141]
- Faculty of Medical Sciences [86157]
- Faculty of Social Sciences [28413]
- Open Access publications [76286]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.